Evaxion organise la journe de la recherche et dveloppement et dvoile le vaste potentiel de sa plateforme AI-Immunology
| EVAX Stock | USD 1.54 0.12 7.23% |
Slightly above 61% of Evaxion Biotech's investor base is looking to short. The analysis of the overall investor sentiment regarding Evaxion Biotech AS suggests that many traders are alarmed. Evaxion Biotech's investing sentiment can be driven by a variety of factors including economic data, Evaxion Biotech's earnings reports, geopolitical events, and overall market trends.
Evaxion |
La plateforme AI-Immunology brevete ouvre la voie dune nouvelle re dans le monde de la dcouverte, de la conception et du dveloppement de vaccins...
Read at globenewswire.com
 |
Evaxion Biotech Fundamental Analysis
We analyze Evaxion Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evaxion Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evaxion Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Evaxion Biotech is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Evaxion Biotech AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evaxion Biotech stock to make a market-neutral strategy. Peer analysis of Evaxion Biotech could also be used in its relative valuation, which is a method of valuing Evaxion Biotech by comparing valuation metrics with similar companies.
Peers
Evaxion Biotech Related Equities
| REVB | Revelation Biosciences | 25.00 | ||||
| PHIO | Phio Pharmaceuticals | 7.35 | ||||
| UNCY | Unicycive Therapeutics | 7.25 | ||||
| QNRX | Quoin Pharmaceuticals | 6.67 | ||||
| LYEL | Lyell Immunopharma | 5.26 | ||||
| BDRX | Biodexa Pharmaceticals | 4.09 | ||||
| VRAX | Virax Biolabs | 1.02 | ||||
| GLUE | Monte Rosa | 1.35 | ||||
| ALLR | Allarity Therapeutics | 1.82 | ||||
| CGEM | Cullinan Oncology | 2.08 | ||||
| RVPH | Reviva Pharmaceuticals | 3.23 | ||||
| ZVSA | ZyVersa Therapeutics | 3.74 | ||||
| ZURA | Zura Bio | 8.20 | ||||
| RVMD | Revolution Medicines | 10.46 | ||||
| RNAZ | Transcode Therapeutics | 20.00 |
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.